VCYT
Veracyte, Inc.Company with tickers: VCYT
CIK
1384101
CUSIP
92337F107
Shares Outstanding
79,792,647
13F Activity (30d)
198 filings
196 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $139,071,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Cost of Revenue | — | ||||
| Gross Profit | $101,159,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Expenses | — | ||||
| Research & Development | $27,098,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Operating Income | $22,646,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| Net Income | $28,707,000 | USD | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Basic) | $0.36 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |
| EPS (Diluted) | $0.35 | USD/shares | 2026-03-31 | 10-Q | 2026-05-06 |